home / stock / nonof / nonof news


NONOF News and Press, Novo-Nordisk A/S From 12/01/23

Stock Information

Company Name: Novo-Nordisk A/S
Stock Symbol: NONOF
Market: OTC
Website: novonordisk.com

Menu

NONOF NONOF Quote NONOF Short NONOF News NONOF Articles NONOF Message Board
Get NONOF Alerts

News, Short Squeeze, Breakout and More Instantly...

NONOF - Pfizer hits new 52-week low after weight loss setback

2023-12-01 12:50:00 ET More on Pfizer, Rhythm Pharma etc. Pfizer Inc. (PFE) 6th Annual Evercore ISI HealthCONx Conference (Transcript) Pfizer Is A Fantastic Buy And So Are These 9%-Yielding Blue Chips Rhythm Pharmaceuticals: Major Catalysts Due For Weight Loss Specia...

NONOF - Novo Nordisk sues Florida pharmacies for selling compounded Wegovy with impurities

2023-11-30 10:38:15 ET More on Novo Nordisk Novo Nordisk: Plenty More Room To Run Despite Its Hefty Valuation Novo Nordisk: Massive Reality Check Awaits Greedy Investors Novo Nordisk: Healthy Gains Ahead, EPS Growth Seen, Technical Strength Eli Lilly weight l...

NONOF - Eli Lilly weight loss drug outperforms Novo Nordisk's in real-world study

2023-11-28 08:17:10 ET More on Eli Lilly Eli Lilly: Perfectly Priced Healthcare Giant Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise Eli Lilly and Company (LLY) Presents at UBS Biopharma 2023 Conference (Transcript) M&A, ...

NONOF - Novo falls as long-time investor cuts stake on weight loss hype

2023-11-27 12:58:26 ET More on Novo Nordisk Novo Nordisk: Plenty More Room To Run Despite Its Hefty Valuation Novo Nordisk: Massive Reality Check Awaits Greedy Investors Novo Nordisk: Healthy Gains Ahead, EPS Growth Seen, Technical Strength Lexaria stock rall...

NONOF - Novo Nordisk: Massive Reality Check Awaits Greedy Investors

2023-11-25 09:00:00 ET Summary Novo Nordisk's stock continues to surge as greedy investors exploit surging momentum, as they fear missing out on further potential gains. The company's impressive Q3 earnings results suggest the upward momentum could continue. I also have not assess...

NONOF - Novo Nordisk to invest $2.3B to ramp up weight-loss drug production in France

2023-11-24 05:25:24 ET Novo Nordisk to ration Ozempic starter kits amid weight loss use Novo Nordisk (NVO) R&D Investor Event (Transcript) Novo Nordisk: Price Could Still Be Justified Novo Nordisk (NVO) Q3 Earnings Call Transcript M&A, GLP-1s to d...

NONOF - Medtronic raises outlook as diabetes segment outperforms in Q2

2023-11-21 07:45:31 ET More on Medtronic Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings Medtronic Stock Is Simply Too Cheap To Ignore Medtronic Faces Potential Decline Despite Financial Strength Medtronic Non-GAAP EPS of $1.25 beats by $...

NONOF - M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey

2023-11-19 12:00:00 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Perfectly Priced Healthcare Giant Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript) Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise ...

NONOF - IQDG: Finding Dividend Growth In Quality And Forward Earnings

2023-11-19 09:56:29 ET Summary WisdomTree International Quality Dividend Growth Fund selects ex-North America dividend stocks with quality and expected earnings growth characteristics. The fund is well-diversified across countries, sectors, and holdings, with a focus on Europe. ...

NONOF - Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings

2023-11-17 09:20:22 ET Summary Medtronic plc will announce its fiscal year 2024 Q2 earnings Tuesday 21st November. Analysts expect Q2 revenues of ~$7.9bn, normalized EPS of $1.18, and GAAP EPS of $0.81. Key areas of focus include the impact of U.S.-China relations, supply chai...

Previous 10 Next 10